Alembic Limited (BOM:506235)

India · Delayed Price · Currency is INR

90.11

-3.67 (-3.91%)

At close: Jun 19, 2026

-21.16% (1Y)

Market Cap	23.14B -18.5%
Revenue (ttm)	2.40B +8.2%
Net Income	3.17B +2.2%
EPS	12.36 +2.2%
Shares Out	256.78M
PE Ratio	7.29
Forward PE	2.35
Dividend	2.40 (2.56%)
Ex-Dividend Date	Aug 5, 2025

Volume	58,624
Open	94.28
Previous Close	93.78
Day's Range	89.60 - 94.28
52-Week Range	70.64 - 125.70
Beta	0.64
Analysts	Hold
Price Target	725.00 (+704.57%)
Earnings Date	Aug 10, 2026

About Alembic

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-genera... [Read more]

Industry Real Estate

Founded 1907

Employees 256

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506235

Full Company Profile

Financial Performance

In fiscal year 2026, Alembic's revenue was 2.40 billion, an increase of 8.16% compared to the previous year's 2.22 billion. Earnings were 3.17 billion, an increase of 2.16%.

Financial Statements